Published • loading... • Updated
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
Summary by The Hamilton Spectator
7 Articles
7 Articles
NiagaraFallsReview.ca+6 Reposted by 6 other sources
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
POWAY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Diazyme Lipoprotein(a) Molarity Assay. This clearance enables clinical laboratories to use the assay…
·Niagara Falls, Canada
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left6Leaning Right1Center0Last UpdatedBias Distribution86% Left
Bias Distribution
- 86% of the sources lean Left
86% Left
L 86%
14%
Factuality
To view factuality data please Upgrade to Premium
